In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $5.26 in the prior trading day, ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed at $4.88, down -7.22%. In other words, the price has decreased by -$7.22 from its previous closing price. On the day, 1.07 million shares were traded. ORIC stock price reached its highest trading level at $5.18 during the session, while it also had its lowest trading level at $4.79.
Ratios:
Our goal is to gain a better understanding of ORIC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.56 and its Current Ratio is at 10.56. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on October 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.
On September 06, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’24 when Piscitelli Dominic sold 8,851 shares for $8.28 per share. The transaction valued at 73,298 led to the insider holds 106,764 shares of the business.
Multani Pratik S sold 8,850 shares of ORIC for $73,293 on Dec 16 ’24. The Chief Medical Officer now owns 46,765 shares after completing the transaction at $8.28 per share. On Dec 16 ’24, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 24,660 shares for $8.28 each. As a result, the insider received 204,214 and left with 778,648 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 346610784 and an Enterprise Value of 100007904.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.36, which has changed by -0.5460465 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.67, while it has fallen to a 52-week low of $5.13. The 50-Day Moving Average of the stock is -41.35%, while the 200-Day Moving Average is calculated to be -46.43%.
Shares Statistics:
The stock has traded on average 1.07M shares per day over the past 3-months and 980930 shares per day over the last 10 days, according to various share statistics. A total of 71.02M shares are outstanding, with a floating share count of 42.99M. Insiders hold about 39.48% of the company’s shares, while institutions hold 72.56% stake in the company. Shares short for ORIC as of 1741910400 were 13969650 with a Short Ratio of 13.11, compared to 1739491200 on 12039954. Therefore, it implies a Short% of Shares Outstanding of 13969650 and a Short% of Float of 19.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
